Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard A Larson

Showing results (1-10 of 383) with videos related to

Pageof 39
Sort By:
Clinical Advances in Hematology & Oncology : H&O|April 28, 2009
Therapeutic monitoring of drug plasma concentrations and improved clinical outcomes in CMLRichard A Larson
Seminars in Oncology|December 19, 2007
Three new drugs for acute lymphoblastic leukemia: nelarabine, clofarabine, and forodesineRichard A Larson
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 17, 2009
Allogeneic hematopoietic cell transplantation is not recommended for all adults with standard-risk acute lymphoblastic leukemia in first complete remissionRichard A Larson
Hematology. American Society of Hematology. Education Program|December 6, 2015
Is there a best TKI for chronic phase CML?Richard A Larson
Hematology. American Society of Hematology. Education Program|November 24, 2005
Acute lymphoblastic leukemia: older patients and newer drugsRichard A Larson
Blood|October 29, 2011
CML: live long and prosperRichard A Larson
Seminars in Hematology|April 18, 2006
Management of acute lymphoblastic leukemia in older patientsRichard A Larson
Chemico-Biological Interactions|October 14, 2009
Micro-RNAs and copy number changes: new levels of gene regulation in acute myeloid leukemiaRichard A Larson
Best Practice & Research. Clinical Haematology|March 6, 2007
Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?Richard A Larson
Blood|November 21, 2015
Is there a best TKI for chronic phase CML?Richard A Larson
Pageof 39

Showing results (1-10 of 383) with videos related to

Sort By:
Pageof 39
Clinical Advances in Hematology & Oncology : H&O|April 28, 2009
Therapeutic monitoring of drug plasma concentrations and improved clinical outcomes in CMLRichard A Larson
Seminars in Oncology|December 19, 2007
Three new drugs for acute lymphoblastic leukemia: nelarabine, clofarabine, and forodesineRichard A Larson
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 17, 2009
Allogeneic hematopoietic cell transplantation is not recommended for all adults with standard-risk acute lymphoblastic leukemia in first complete remissionRichard A Larson
Hematology. American Society of Hematology. Education Program|December 6, 2015
Is there a best TKI for chronic phase CML?Richard A Larson
Hematology. American Society of Hematology. Education Program|November 24, 2005
Acute lymphoblastic leukemia: older patients and newer drugsRichard A Larson
Blood|October 29, 2011
CML: live long and prosperRichard A Larson
Seminars in Hematology|April 18, 2006
Management of acute lymphoblastic leukemia in older patientsRichard A Larson
Chemico-Biological Interactions|October 14, 2009
Micro-RNAs and copy number changes: new levels of gene regulation in acute myeloid leukemiaRichard A Larson
Best Practice & Research. Clinical Haematology|March 6, 2007
Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?Richard A Larson
Blood|November 21, 2015
Is there a best TKI for chronic phase CML?Richard A Larson
Pageof 39